# Firstkind Limited

- Location (FDA's records): High Wycombe, GB
- FDA decisions: 12 (2014–2022): 12 510(k) clearances
- Names in FDA's records: Firstkind Limited (11); Firstkind, Ltd. (1)
- Product codes: IPF (10), NGX (2)
- 510(k) review time since 2016: median 64 days, against 110 for FDA's reviews in the same codes and years (7 of 9 faster)
- Predicates its devices cite: 13 (10 its own); citations of its devices by later devices: 10 (10 its own)
- Recalls linked to its devices: 0 (0 Class I)
- Data: FDA decisions to Oct 25, 2026; recalls to Oct 12, 2026

## Firms whose devices it cites most
- Mettler Electronics Corp.: 1 (https://510kreport.com/company/mettler-electronics)
- Chattanooga Group, Inc.: 1 (https://510kreport.com/company/chattanooga-group)
- Flowaid Medical Technologies, Corp: 1 (https://510kreport.com/company/flowaid-medical-technologies)

## Its most-cited devices
- K180082: geko T-2 and geko Plus R-2 (2018), cited by 3
- K152677: geko T-2 Neuromuscular Stimulator (2015), cited by 2
- K133638: GEKO (2014), cited by 1
- K181059: geko T-3 Neuromuscular Stimulator (2018), cited by 1
- K134001: Firefly (2014), cited by 1
- K160299: geko (TM) Plus R-2 Neuromuscular Stimulator (2016), cited by 1

## Recent decisions
- K220327: geko W-3 (Mar 4, 2022)
- K212762: geko W-2 (Nov 29, 2021)
- K201131: firefly T-2 (May 28, 2020)
- K193045: geko™ W-2 (Jan 18, 2020)
- K191113: geko T-2 and geko T-3 Neuromuscular Stimulators (Sep 18, 2019)
- K181059: geko T-3 Neuromuscular Stimulator (May 23, 2018)
- K180082: geko T-2 and geko Plus R-2 (Feb 11, 2018)
- K163125: geko™ T-2 and geko™ Plus R-2 Neuromuscular Stimulators (Apr 10, 2017)

Source page: https://510kreport.com/company/firstkind